<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98">
 <label>98</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meyer</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Feldon</surname>
    <given-names>J</given-names>
   </name>
  </person-group>
  <article-title>To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models</article-title>. 
  <source>Neuropharmacology</source> (
  <year>2012</year>) 
  <volume>62</volume>(
  <issue>3</issue>):
  <page-range>1308â€“21</page-range>. 
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.01.009</pub-id>
 </mixed-citation>
</ref>
